Skip to main content

GOLDMAN SACHS GROUP INC

Position in MESO — Mesoblast Ltd

CIK 886982 NEW YORK, NY

Position in MESO

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$6,109,166
-$1,031,968 QoQ
Shares Held
397,215
+0.3% QoQ
Ownership
0.306%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2025
5 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in MESO Over Time

Shares Held

Position Value (USD)

Derivatives in MESO

reported options exposure · as of Sep 30, 2025
CallValue
$1,611,000
CallShares
100,000
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

GOLDMAN SACHS GROUP INC holds $10,294,260,512 across 365 Biotechnology names. MESO ranks #169 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in MESO

Export CSV
6 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $6,109,166 397,215
2025-12-31 $7,141,134 395,850
2025-09-30 $1,611,000 100,000
2025-09-30 $6,561,280 407,280
2025-06-30 $4,524,413 415,465
2025-03-31 $3,209,144 257,143